At the time of writing, Eton Pharmaceuticals Inc [ETON] stock is trading at $16.91, up 0.71%. An important factor to consider is whether the stock is rising or falling in short-term value. The ETON shares have gain 2.18% over the last week, with a monthly amount glided 9.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Eton Pharmaceuticals Inc [NASDAQ: ETON] stock has seen the most recent analyst activity on January 23, 2025, when H.C. Wainwright reiterated its Buy rating and also boosted its price target to $33 from $17. Previously, B. Riley Securities started tracking the stock with Buy rating on January 10, 2025, and set its price target to $21. On January 06, 2025, H.C. Wainwright reiterated its Buy rating and revised its price target to $17 on the stock. Craig Hallum initiated its recommendation with a Buy and recommended $8 as its price target on May 06, 2024. In a note dated January 04, 2021, H.C. Wainwright reiterated an Buy rating on this stock and revised its target price from $20 to $15.
For the past year, the stock price of Eton Pharmaceuticals Inc fluctuated between $11.09 and $23.00. Currently, Wall Street analysts expect the stock to reach $25 within the next 12 months. Eton Pharmaceuticals Inc [NASDAQ: ETON] shares were valued at $16.91 at the most recent close of the market. An investor can expect a potential return of 47.84% based on the average ETON price forecast.
Analyzing the ETON fundamentals
According to Eton Pharmaceuticals Inc [NASDAQ:ETON], the company’s sales were 70.32M for trailing twelve months, which represents an 117.54% jump. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.09%, and Net Profit Margin reading is -0.1%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.28 and Total Capital is -0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 16.74 points at the first support level, and at 16.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.04, and for the 2nd resistance point, it is at 17.17.
Ratios To Look Out For
It is important to note that Eton Pharmaceuticals Inc [NASDAQ:ETON] has a current ratio of 1.63. On the other hand, the Quick Ratio is 1.25, and the Cash Ratio is 0.84. Considering the valuation of this stock, the price to sales ratio is 6.45, the price to book ratio is 19.61.
Transactions by insiders
Recent insider trading involved Gruber James R., Officer, that happened on Dec 12 ’25 when 5450.0 shares were purchased. Officer, BRYNJELSEN SEAN completed a deal on Dec 12 ’25 to buy 8035.0 shares. Meanwhile, Officer Erdogan-Trinkaus Ipek bought 99.0 shares on Dec 12 ’25.
